Patents Assigned to SWIPP AB
  • Oral film unit dosage form
    Patent number: 12629380
    Abstract: The present invention relates to oral films containing an active pharmaceutical ingredient (API) capable of providing seizure relief and one or more film-forming polymers, the use of such films, for example for the acute treatment of ongoing seizures, and methods for preparing such films. The film according to the invention is characterized by a rapid dissolution in the buccal cavity followed by a rapid and high systemic absorption.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: May 19, 2026
    Assignee: Swipp AB
    Inventors: Bengt Westrin, Nicolas Rollet, Justine de la Prunarède
  • COMPOSITIONS OF MIDAZOLAM FOR BUCCAL ADMINISTRATION IN THE TREATMENT OF SEIZURES TO OBTAIN RAPID ONSET OF ACTION
    Publication number: 20200306260
    Abstract: The present invention relates to a unit dosage composition in the form of a film or a water containing from 0.25 mg to 2 mg of midazolam or a pharmaceutically acceptable salt thereof, and a film-forming substance.
    Type: Application
    Filed: March 6, 2020
    Publication date: October 1, 2020
    Applicant: SWIPP AB
    Inventor: Christer SJÖGREN
  • COMPOSITIONS OF MIDAZOLAM FOR BUCCAL ADMINISTRATION IN THE TREATMENT OF SEIZURES TO OBTAIN RAPID ONSET OF ACTION
    Publication number: 20180221384
    Abstract: The present invention relates to a unit dosage composition in the form of a film or a water containing from 0.25 mg to 2 mg of midazolam or a pharmaceutically acceptable salt thereof, and a film-forming substance.
    Type: Application
    Filed: July 15, 2016
    Publication date: August 9, 2018
    Applicant: SWIPP AB
    Inventor: Christer SJÖGREN